NRXPW icon

NRX Pharmaceuticals, Inc. Warrant

19 hedge funds and large institutions have $696K invested in NRX Pharmaceuticals, Inc. Warrant in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
BFM
1
Boothbay Fund Management
New York
$360K
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$82K +$38.2K +174,600 +87%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$44K +$44K +187,500 New
VAS
4
VR Advisory Services
Cayman Islands
$35K
OAM
5
Oxford Asset Management
United Kingdom
$25K
AA
6
AQR Arbitrage
Connecticut
$24K
PC
7
Periscope Capital
Ontario, Canada
$23K
KPF
8
K2 Principal Fund
Ontario, Canada
$22K +$22K +101,200 New
6CM
9
683 Capital Management
New York
$18K
YCM
10
Yakira Capital Management
Connecticut
$18K
GCL
11
Glazer Capital LLC
New York
$15K +$4.29K +19,078 +40%
CI
12
Cowen Inc
New York
$15K +$15K +67,000 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$7K +$345 +1,459 +5%
Walleye Trading
14
Walleye Trading
New York
$3K
LIM
15
Longfellow Investment Management
Massachusetts
$2K -$8K -45,200 -80%
HIM
16
HGC Investment Management
Ontario, Canada
$2K +$2K +5,503 New
UBS Group
17
UBS Group
Switzerland
$1K
RCM
18
Rivernorth Capital Management
Florida
$26
BI
19
Bulldog Investors
New Jersey
$25 -$2 -8,000 -7%
WCMNY
20
Westchester Capital Management (New York)
New York
-$22K -122,379 Closed
BCM
21
Bluefin Capital Management
New York
-$18K -101,600 Closed